scholarly journals A prospective study of evaluation of methods to decrease the morbidity in oral submucous fibrosis

2015 ◽  
Vol 1 (1) ◽  
pp. 28 ◽  
Author(s):  
Dr. Kamal Devgan ◽  
Dr. Priyank Mistry ◽  
Dr. Tapan Nagpal
Keyword(s):  
Oral Cavity ◽  
Prospective Study ◽  
Oral Submucous Fibrosis ◽  
Mouth Opening ◽  
Burning Pain ◽  
Chronic Disorder ◽  
Submucous Fibrosis ◽  
A Prospective Study ◽  
Upper Third ◽  
Tongue Mobility

Aim: To evaluate the effect of antioxidants, intralesional steroids and laser in decreasing morbidity in patients of oral submucous fibrosisIntroduction: Oral submucous fibrosis (OSMF) is a chronic disorder characterized by progressive fibrosis of the lining mucosa of the upper digestive tract involving the oral cavity, oropharynx, and rarely the upper third of the esophagus, resulting in intolerance to spicy foods, burning sensation in the mouth, limitation of mouth opening and tongue mobility, xerostomia, dysphagia and hoarseness. OSMF has been reported to occur commonly in conjunction with premalignant diseases such as leukoplakia and lichen planus and therefore aprecursor to oral cavity cancer in many cases.Materials and Methods: This prospective study included 60 patients with OSMF attending the Ear Nose & Throat Clinic of Dhiraj Hospital, Piparia. Patients of OSMF were evaluated as per Performa and for proper treatment planning were broadly classified into 4 groups based on classification suggested by Sinha et al.Conclusion: Lycopene, an antioxidant has significant response in early cases of OSMF in decreasing the burning pain in oral cavity in OSMF. Inj. triamcinolone and Inj. hyaluronidase, given submucosally havesignificant response in early cases of OSMF to improve cheek flexibility.CO2 laser have significant results in achieving satisfactory mouth opening in OSMF but notcheek flexibility.

Estimation of Serum Folate and Homocysteine Levels in Oral Submucous Fibrosis-A Prospective Study

2017 ◽  
Vol 5 (2) ◽  
pp. 110
Author(s):  
Pushpanjali ◽  
Dayanandam ◽  
M. Satyasree ◽  
Seelam Divya ◽  
Pravallika Pasupulati ◽  
...  
Keyword(s):  
Prospective Study ◽  
Oral Submucous Fibrosis ◽  
Serum Folate ◽  
Submucous Fibrosis ◽  
A Prospective Study

scholarly journals Oral Submucous Fibrosis - A Review

2021 ◽  
Vol 10 (32) ◽  
pp. 2665-2671
Author(s):  
Falguni Patel ◽  
Shreyas N. Shah ◽  
Christina James
Keyword(s):  
Oral Cavity ◽  
Precancerous Lesions ◽  
Oral Submucous Fibrosis ◽  
Classification Systems ◽  
Oral Disease ◽  
Areca Nut ◽  
Functional Aspects ◽  
Premalignant Condition ◽  
Submucous Fibrosis ◽  
Upper Third

A common oral disease named as oral submucous fibrosis (OSMF) has the tendency to usually affect many areas of the oral cavity as well as involving the area of pharynx. The characteristic feature of oral submucous fibrosis is the fibrosis in submucosal area which involves maximum part of oral cavity leading to advanced lock jaw as a result of rigidity in cheeks, pharynx, lips and upper third part of the oesophageal canal progressing to dysphagia. It has been reported that OSMF occurs mainly in persons who are habituated to chew areca nut or products containing areca nut along with other ingredients. In recent years with the introduction of commercially available Gutka and other areca nut products, the incidence of OSMF is increasing especially in the younger generations. OSMF is irreversible and persists even after cessation of chewing habit and the severity increases along with the duration of habit. In 2007, the categorization of oral submucous fibrosis was done as a premalignant condition by WHO and it has higher chances of malignant transformation. Early diagnosis and application of proper treatment modality is mandatory to reduce morbidity and mortality rate. There are many classification systems that have been proposed in literature for oral submucous fibrosis, among which many are based on clinical features, some of them on functional aspects and others are based on histopathological aspects. Here is an attempt to enlighten the facts and recent updates of clinical, functional, histopathological features as well as pathogenesis and management of oral submucous fibrosis. The complete knowledge of oral submucous fibrosis is a useful to the clinicians as well as academicians and researchers for timely detection and proper management of the disease. KEY WORDS Oral Submucous Fibrosis, Precancerous Lesions, Precancerous Conditions, Sclerosing Stomatitis

Epithelial atrophy, fibrosis and vascularity correlation with epithelial dysplasia in oral submucous fibrosis, a prospective study

2020 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
Ruchika Kapoor ◽  
Kaustubh Sansare ◽  
Sandhya Tamgadge ◽  
Freny Karjodkar ◽  
Archana Mehra ◽  
...  
Keyword(s):  
Prospective Study ◽  
Oral Submucous Fibrosis ◽  
Epithelial Dysplasia ◽  
Submucous Fibrosis ◽  
A Prospective Study

scholarly journals Oral Submucous Fibrosis: An Overview

2017 ◽  
Vol 1 (1) ◽  
pp. 22-26
Author(s):  
Ramandeep S Narang
Keyword(s):  
Oral Cavity ◽  
Severe Disease ◽  
Oral Submucous Fibrosis ◽  
Combination Drug ◽  
Slaked Lime ◽  
Potentially Malignant ◽  
Submucous Fibrosis ◽  
Upper Third ◽  
Malignant Condition ◽  
Combination Drug Treatment

ABSTRACT Oral submucous fibrosis (OSMF) is a chronic and potentially malignant condition of the oral cavity. It occurs predominantly in India and Southeast Asia. The pathogenesis of OSMF is not well established, but it is believed to be multifactorial. Chewing of betel quid (containing areca nut, tobacco, and slaked lime) has been recognized as one of the most important risk factors. It is characterized by a juxtaepithelial inflammatory reaction followed by fibroelastic changes in the lamina propria and associated epithelial atrophy. The disease affects most parts of the oral cavity as well as the upper third of the esophagus. The abnormal fibrosis causes blanching and stiffness of the mouth, with eventual immobility of the lips, cheeks, tongue, soft palate, and uvula. Treatment of OSMF is difficult; a combination drug treatment is administered. In patients with severe disease, physical therapy and/or surgery is added to drug therapy. How to cite this article Narang RS, Arora A. Oral Submucous Fibrosis: An Overview. Curr Trends Diagn Treat 2017;1(1):22-26.

scholarly journals Maintenance of Increased Mouth Opening in Oral Submucous Fibrosis Patient Treated with Nasolabial Flap Technique

2014 ◽  
Vol 2014 ◽  
pp. 1-4
Author(s):  
Milind Naphade ◽  
Bhushan Bhagat ◽  
Dwarkadas Adwani ◽  
Ranjit Mandwe
Keyword(s):  
Chronic Disease ◽  
Oral Cavity ◽  
Oral Mucosa ◽  
Oral Submucous Fibrosis ◽  
Mouth Opening ◽  
Oral Carcinoma ◽  
Nasolabial Flap ◽  
Flap Technique ◽  
Submucous Fibrosis ◽  
Malignant Changes

Oral submucous fibrosis (OSMF) is an insidious chronic disease affecting any part of the oral cavity and sometimes the pharynx with epithelial atrophy leading to stiffness of the oral mucosa, causing trismus and inability to eat. However, a more serious complication of this disease is the risk of the development of oral carcinoma. A case of OSMF reported with initial interincisal mouth opening; 8 mm which was treated surgically with nasolabial flap technique followed by active mouth opening exercises for 6 months with Hister’s jaw exerciser. The patient could maintain mouth opening of 32 mm at the end of 18-months followup. The patient was observed closely for any malignant changes in the oral cavity.

scholarly journals EVALUATION OF FACTORS RESPONSIBLE FOR THE OCCURRENCE OF ORAL SUBMUCOUS FIBROSIS IN PATIENTS REFERRED TO DARBHANGA MEDICAL COLLEGE AND HOSPITAL

2020 ◽  
Vol 4 (2) ◽  
Author(s):  
Keshav Kumar ◽  
TabitaJoy Chettiankandy
Keyword(s):  
Oral Cavity ◽  
Indian Subcontinent ◽  
Oral Submucous Fibrosis ◽  
Mouth Opening ◽  
Young Generation ◽  
Chewing Tobacco ◽  
Medical College ◽  
Public Health Professionals ◽  
Submucous Fibrosis ◽  
To Come

Oral submucous fibrosis (OSF) is a chronic progressive and irreversible disease affecting the oral, oropharyngeal, and sometimes the esophageal mucous. OSF is a disease that causes changes similar to those of systemic sclerosis (scleroderma) but limited to oral tissues. The disease is seen in those from the Indian subcontinent and from many parts of South-East Asia. It causes significant morbidity (in terms of loss of mouth function as tissues become rigid and mouth opening becomes difficult) and mortality (when transformation into squamous cell carcinoma occurs). The introduction of chewing tobacco containing areca nut into the market has been associated with a sharp increase in the frequency of OSF. Hence based on above findings the present study was planned for Evaluation of Factors Responsible for the Occurrence of Oral Submucous Fibrosis in Patients Referred to Darbhanga Medical College and Hospital. The present study was carried out in the Department of Dentistry, Darbhanga Medical College and Hospital Laheriasarai, Darbhanga Bihar. In the present study 30 cases of the oral submucous fibrosis were enrolled. Oral submucous fibrosis (OSMF) is a chronic insidious disease affecting any part of the oral cavity and sometimes the pharynx. Although, occasionally preceded by or associated with vesicle formation, it is always associated with a juxta-epithelial inflammatory reaction. It is important that preventive efforts be carried out by the concerned authorities and public health professionals in establishing tobacco cessation clinics and tobacco awareness education in such masses (especially the young generation) along with a long standing and a close knit motivation program that enables our future generations to come to avoid the menace of tobacco and its subsequent health effects. Keywords: Oral submucous fibrosis, OSF, oral cavity, Bihar.

Sign in / Sign up

Export Citation Format

Share Document